Screener
Aurinia Pharmaceuticals AUPH Japan — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Aurinia Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 6:06 AM EST
- Fiscal year
- FY2025
- Accession
- 0001600620-26-000017
FAQ
- What is Aurinia Pharmaceuticals's japan — revenue?
- Aurinia Pharmaceuticals (AUPH) reported japan — revenue of $4.8M in Q4 2025.
- How has Aurinia Pharmaceuticals's japan — revenue changed year-over-year?
- Aurinia Pharmaceuticals's japan — revenue decreased by 23.3% year-over-year, from $6.26M to $4.8M.
- What does japan — revenue mean?
- This metric represents the total gross revenue generated from pharmaceutical product sales and licensing activities within the Japanese geographic market. It serves as a key indicator of the company's international commercial footprint and the successful adoption of its therapeutic portfolio in this specific region. Monitoring this figure helps investors assess the company's ability to navigate foreign regulatory environments and capture market share outside of its primary domestic territory.
Ask your AI about Aurinia Pharmaceuticals's japan — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude